Coordination of omnichannel outreach and physician behavior can impact script adoption, forecasting, patient outcomes and overall product success.

Innovative outsourced commercialization model eliminates overspend by 20%+ based on research from 10 real-world pharma launches.

Real-world evidence (RWE), is helping bridge the drug development gap, giving power to the patient voice and providing in-depth looks at performance.

An estimated $3.9 billion in revenue was lost from mature brands vs. promoted brands during the pandemic. Experts explain how to reignite revenue.

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

The commercialization of innovative therapies is complex. Article highlights three keys to value for unlocking the promise of cell therapies.

An end-to-end commercialization model for manufacturers seeking to reduce risk, maintain full ownership and capture full revenue potential.

Key trends and three proven strategies for pharma to boost momentum, make up lost sales and create value for stakeholders.

Outsourced commercialization is the revolution pharma needs to protect revenue and collaborate with patients to provide access to critical therapies.

In an era of limited access to key decision makers, how are you mobilizing your field force to communicate the value of your brands and real-world evi